Mercer Global Advisors
ATNM icon

Mercer Global Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Mercer Global Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59 Buy
+60
New +$69 ﹤0.01% 6001

Other funds holding ATNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $5.2B AUM 22.05% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
GBFG
Gerald Baker Financial Group Arlington, Texas $351M AUM
ML
Mayport LLC Newton, Massachusetts $645M AUM 19.45% 1-Year Est. Return

Mercer Global Advisors's ATNM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Actinium Pharmaceuticals (ATNM) in Q2 2026: 60 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #6001 among its holdings.

21 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Mercer Global Advisors held 60 shares of Actinium Pharmaceuticals worth $59 as of Q2 2026.
  • Actinium Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6001 holding.
  • 21 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.